Variant · Snv
EIF2B2 NM_014239.4(EIF2B2):c.285-1G>A
CI-VAR-00198130Explore in graph →NM_014239.4:c.285-1G>AClinVar 1205361 rs373906805
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1205361 | Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Vanishing white matter disease; Leukoencephalopathy with vanishing white matter 2; Clear cell carcinoma of kidney; Leukoencephalopathy with vanishing white matter 1 | germline | 6 | Apr 29, 2026 | clinvar |